IGF-1R antibody and its use for the diagnosis of cancer
US10753937B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 27, 2016 |
| Grant date | Aug 25, 2020 |
| Priority date | — |
| Expiry date | Apr 27, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to IGF-IR (insulin like growth factor receptor-1) antibodies characterized by CDR sequences a, to be used in detection methods of IGF-IR expressing tumoral cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.